PlainRecalls
FDA Devices Moderate Class II Ongoing

(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology; and (2) CryoPatch SG Pulmonary Human Cardiac Branch Patch, SGP020, Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology.

Reported: August 14, 2024 Initiated: May 28, 2024 #Z-2532-2024

Product Description

(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology; and (2) CryoPatch SG Pulmonary Human Cardiac Branch Patch, SGP020, Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology.

Reason for Recall

Grafts were found to have been approved, released, shipped and implanted with an invalid test results.

Details

Recalling Firm
Artivion, Inc
Units Affected
2 arteries, 1 patch
Distribution
US Nationwide distribution in the states of CA, DC, FL, and NY.
Location
Kennesaw, GA

Frequently Asked Questions

What product was recalled?
(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology; and (2) CryoPatch SG Pulmonary Human Cardiac Branch Patch, SGP020, Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology.. Recalled by Artivion, Inc. Units affected: 2 arteries, 1 patch.
Why was this product recalled?
Grafts were found to have been approved, released, shipped and implanted with an invalid test results.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 14, 2024. Severity: Moderate. Recall number: Z-2532-2024.